IBM’s Quantum and Agent Bets Face Consulting Headwinds
29.06.2026 - 03:53:38 | boerse-global.de
IBM shares have clawed their way back to a pivotal technical level, but the next few days will determine whether the rally has legs. After a 7% weekly gain that lifted the stock to €237.80, the price is hugging its 200-day moving average of €235.90. The next major catalyst arrives on July 22, when the company reports second-quarter earnings. With the stock down roughly 4% year to date, the market is demanding proof that Big Blue’s transformation is generating real revenue, not just headlines.
The narrative around IBM has shifted dramatically since the start of the year. Management has positioned the company as a heavyweight in both artificial intelligence and national security infrastructure. In late June, CEO Arvind Krishna stood alongside US officials as they signed new quantum computing decrees, cementing IBM’s role as a cornerstone of government technology. A $2 billion federal budget will underwrite the development of research-capable quantum computers by 2028, with a mandate for all US agencies to adopt quantum-safe encryption by 2031. An additional $1 billion from the CHIPS Act is funding the bridge between lab research and industrial hardware.
That long?term policy tailwind, however, runs alongside a more immediate earnings test. The consulting division, once the steady engine of IBM’s services business, has been sputtering. In April, the market punished the shares despite strong cash flows because consulting growth remained sluggish. For the full year, management has guided for software revenue to expand at least 10%, while consulting is expected to grow only in the low single digits. Currently, about 30% of the consulting backlog involves generative AI projects — a proportion that, if converted to billings, could quiet sceptics.
Should investors sell immediately? Or is it worth buying IBM?
The real wild card is the proliferation of autonomous AI agents. According to Gartner, by the end of 2026, 40% of enterprise applications will integrate such agents, up from less than 5% last year. IBM is betting that its focus on control and multi?cloud orchestration will appeal to regulated clients willing to pay a premium for security. An internal IBM study found that companies with robust AI oversight deploy 16 times more agents than those with manual controls, while spending less and earning higher margins. That thesis is being tested by the street, which wants to see agent?related revenue start to show up in the numbers.
Hardware innovations add another layer to the story. IBM recently demonstrated the world’s first sub?1?nanometer chip technology, using nanostack transistors and 2D materials to promise up to 50% better energy efficiency. Though mass production is still years away, the prototype addresses the electricity?hungry reality of modern AI data centers. The mainframe unit, IBM Z, has already felt the benefit: first?quarter revenue jumped 51% year on year, turning a formerly stodgy division into the company’s fastest?growing business.
The $11 billion acquisition of Confluent, completed earlier this year, is another piece management must prove was worth the price. Confluent’s real?time data tools were meant to slot seamlessly into IBM’s AI platform, but cross?selling results remain unproven. Analysts have set an average price target of roughly €258, implying about 8.5% upside from current levels. The stock’s recent RSI reading of 56 — slightly above the neutral midpoint — suggests there is room to run, provided the earnings report does not disappoint.
Technically, the situation is tense. A close below the 200?day line after July 22 would be taken as a vote of no confidence, locking in the year?to?date loss. On the upside, breaking through the €250 psychological barrier would reopen the path toward the analyst target. With annualized volatility near 70%, the market is bracing for a sharp move in either direction. IBM’s mix of government?backed quantum research, sub?1?nanometer silicon, and agent?driven software gives it a defensive sheen that many pure?play AI stocks lack. Whether that combination is enough to overcome the consulting drag will become clear when the numbers land.
Ad
IBM Stock: New Analysis - 29 June
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
